ZoomRx ASCO25 Survey ASCO25 Oncologists’ Perspective: Not a “lame-duck” conference! Immediate practice-changing developments recognized, along with a promise of major transformations in the longer term The American Society of Clinical Oncology's 2025 Annual Meeting defied industry expectations, delivering meaningful clinical advances that have the potential to change oncology practice. Despite some industry analysts describing #ASCO25 as lacking in
Brand Builder Core Visual Aid Research Drives Brand Optimization Executive Summary Successful pharmaceutical brands require more than just compelling messaging and creative concepts - they demand effective sales execution. The core visual aid (CVA) and its delivery serve as the primary vehicles
Sagan ZoomRx Launches 'Sagan' – An AI-Powered Platform Revolutionizing Pharma Market Research Published on EIN Presswire Sagan combines AI and real human voices through natural conversation to deliver market research insights with unprecedented speed and scale. "Sagan is ending the compromise between qualitative depth and
Brand Builder Target Product Profile (TPP) Optimization: Maximizing Launch Success Through Strategic Clinical Endpoints Evaluation Executive Summary Target Product Profile (TPP) optimization represents a critical early investment in pharmaceutical launch planning. By evaluating how various clinical trial outcomes influence physician prescribing decisions and market opportunity, organizations can develop
Brand Builder ASCO 2025 Preview: Oncology Pipeline Dynamics and Healthcare Provider Priorities ADCs & Bispecifics Lead Oncologist Excitement for Emerging Cancer Therapies Healthcare Provider Sentiment Toward Emerging Cancer Therapeutics As the oncology community prepares for American Society of Clinical Oncology's annual meeting in 2025, new research
Media Tracking How Behavioral Data Revealed Zepbound’s Momentum Market share doesn’t shift overnight, but the signals start early. HCPs signal intent through research long before they prescribe. In the obesity market, Zepbound’s rise was visible in attention metrics well
Promotional Tracking What 14,000+ Pharmaceutical Messages Reveal from our decade long Promotional Tracking? Pharmaceutical promotional messages operate in a world of extraordinary complexity. Every word carries weight. Every phrase must navigate regulatory requirements while simultaneously inspiring healthcare professionals to act. The challenge? Crafting messages that cut
Promotional Tracking Oncology Pharma Manufacturer Perception Report - Q2'25 Executive Summary The oncology pharmaceutical landscape in 2025 is fiercely competitive, with healthcare professionals (HCPs) placing a premium on innovation and patient-centricity. ZoomRx surveyed 50 US-based oncologists and hem-oncologists to evaluate perceptions of
Promotional Tracking Immunology Pharma Manufacturer Perception Report - Q2'25 Executive Summary In the ever-evolving pharmaceutical industry, the perception of healthcare professionals (HCPs) can make or break a company's success. Understanding what HCPs value and how they perceive different pharma manufacturers is essential
Media Tracking Beyond Vanity Metrics: How Traditional Digital Performance Metrics are Misleading Pharma Marketers If you're only tracking owned properties, you're missing 90% of the story and the critical insights shaping HCP treatment decisions. Comprehensive behavioral intelligence fills this gap, empowering pharmaceutical marketers to make confident, evidence-based
Brand Builder Research Insights for Effective Creative Concepts Executive Summary Compelling creative concepts are essential for successful unbranded disease state education and branded promotional campaigns. Creative concepts define the visual identity and emotional core of how a campaign connects with its
ZoomRx Cracking Pharma’s AI Code: How ZoomRx Breaks Down Data, Talent, and Strategy Barriers Artificial intelligence (AI) is reshaping drug development, promising to accelerate timelines and uncover new therapeutic opportunities. However, as highlighted in the recent Wall Street Journal article “Pharma Companies Turn to AI to Speed
ZoomRx The Vaccine-Autism Debate: What Doctors Really Think The Battle Behind the Exam Room Door For years, the debate over vaccines and autism has raged in the public square, fueled by viral misinformation, political polarization, and persistent parental anxiety. But what
HCP Community AAN 2025: Navigating the Future of Neurological Care Balancing Innovation with Practical Realities in an Evolving Treatment Landscape Executive Summary The AAN 2025 conference showcased advancements in neurological care, including new therapies and clinical strategies. While these developments offer potential, their
Media Tracking False Impressions: How Pharma Brands Are Misled by Digital Reach Metrics New data reveals the scale of waste in digital media spend, but a new kind of tool is helping pharma brands cut through the noise and plan with precision. TL;DR: What You
Brand Builder Competitive Landscape Research: Future-Scaping for Launch Excellence Executive Summary Anticipating future competitive dynamics is essential for pharmaceutical brand launch. Forward-looking competitive analysis enables organizations to shape clinical development strategies, refine positioning approaches, and optimize resource allocation well before market entry.
HCP-Pt Revolutionizing Patient Journey in Healthcare: Real Conversations Driving Personalized Support "I'm scared, doctor. Will this new treatment really work for me?" This poignant question, captured in a clinical conversation, encapsulates the deeply personal nature of every patient's healthcare journey. In an era of
Promotional Tracking Unveiling the Mindshare Battle in Psychiatric Drugs What drives Psychiatrists’ Awareness and Excitement in a space with multiple alternatives? Executive Summary The psychiatric drug market is fiercely competitive, with healthcare professionals (HCPs) navigating a crowded landscape of approved and pipeline
Ferma Congress Advancing the Fight Against NSCLC: Key Highlights from AACR 2025 The AACR Annual Meeting 2025 is set to unveil groundbreaking advancements in the fight against non-small cell lung cancer (NSCLC). This year’s conference will spotlight emerging therapies, novel biomarkers, and cutting-edge research
Ferma Congress Breaking New Ground in Breast Cancer Research: Key Highlights from AACR 2025 As the global oncology community prepares for the American Association for Cancer Research (AACR) Annual Meeting 2025 with the abstract release this week, the spotlight is on groundbreaking advancements in breast cancer research.
HCP-Pt Bridging the Gap: Aligning HCP and Patient Lexicons for More Effective Communication "Doctor, can you explain that again? I'm not sure I understand all those medical terms." This common refrain in exam rooms across the country highlights a critical challenge in healthcare communication: the gap
Brand Builder Bridging Insights to Action: How Effective Workshops Drive Research ROI for Pharmaceutical Teams Executive Summary In today's budget-constrained pharmaceutical landscape, converting research insights into strategic action remains a critical challenge for market research and brand teams. This white paper examines how structured workshops bridge the gap
Promotional Tracking Evaluating Messaging Benchmarks Across Key Therapeutic Areas: Oncology, Rare Disease, and Immunology Following our prior analysis of overarching trends in healthcare professional (HCP) message recall and effectiveness across the pharmaceutical market, we’ve now explored three key therapeutic areas in greater depth: Oncology, Rare Disease,
ZoomRx Breaking the Chains: How AI is Revolutionizing Pharmaceutical Market Research Forever Gone are the days when pharmaceutical companies had to choose between deep insights or broad sample sizes. The age-old trade-off that has handcuffed market researchers for decades is finally crumbling, thanks to advancements
ZoomRx The Synthetic Mirage: Why AI-Generated Data Falls Short in Life Sciences Market Research Imagine a world where market research is conducted without ever speaking to a real person. Sounds efficient, right? But what if this efficiency comes at the cost of accuracy and insight? The life
